Cargando…
Perfused 3D angiogenic sprouting in a high-throughput in vitro platform
Angiogenic sprouting, the growth of new blood vessels from pre-existing vessels, is orchestrated by cues from within the cellular microenvironment, such as biochemical gradients and perfusion. However, many of these cues are missing in current in vitro models of angiogenic sprouting. We here describ...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510881/ https://www.ncbi.nlm.nih.gov/pubmed/30171498 http://dx.doi.org/10.1007/s10456-018-9647-0 |
_version_ | 1783417490560253952 |
---|---|
author | van Duinen, V. Zhu, D. Ramakers, C. van Zonneveld, A. J. Vulto, P. Hankemeier, T. |
author_facet | van Duinen, V. Zhu, D. Ramakers, C. van Zonneveld, A. J. Vulto, P. Hankemeier, T. |
author_sort | van Duinen, V. |
collection | PubMed |
description | Angiogenic sprouting, the growth of new blood vessels from pre-existing vessels, is orchestrated by cues from within the cellular microenvironment, such as biochemical gradients and perfusion. However, many of these cues are missing in current in vitro models of angiogenic sprouting. We here describe an in vitro platform that integrates both perfusion and the generation of stable biomolecular gradients and demonstrate its potential to study more physiologically relevant angiogenic sprouting and microvascular stabilization. The platform consists of an array of 40 individually addressable microfluidic units that enable the culture of perfused microvessels against a three-dimensional collagen-1 matrix. Upon the introduction of a gradient of pro-angiogenic factors, the endothelial cells differentiated into tip cells that invaded the matrix. Continuous exposure resulted in continuous migration and the formation of lumen by stalk cells. A combination of vascular endothelial growth factor-165 (VEGF-165), phorbol 12-myristate 13-acetate (PMA), and sphingosine-1-phosphate (S1P) was the most optimal cocktail to trigger robust, directional angiogenesis with S1P being crucial for guidance and repetitive sprout formation. Prolonged exposure forces the angiogenic sprouts to anastomose through the collagen to the other channel. This resulted in remodeling of the angiogenic sprouts within the collagen: angiogenic sprouts that anastomosed with the other perfusion channel remained stable, while those who did not retracted and degraded. Furthermore, perfusion with 150 kDa FITC-Dextran revealed that while the angiogenic sprouts were initially leaky, once they fully crossed the collagen lane they became leak tight. This demonstrates that once anastomosis occurred, the sprouts matured and suggests that perfusion can act as an important survival and stabilization factor for the angiogenic microvessels. The robustness of this platform in combination with the possibility to include a more physiological relevant three-dimensional microenvironment makes our platform uniquely suited to study angiogenesis in vitro. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10456-018-9647-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6510881 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-65108812019-05-28 Perfused 3D angiogenic sprouting in a high-throughput in vitro platform van Duinen, V. Zhu, D. Ramakers, C. van Zonneveld, A. J. Vulto, P. Hankemeier, T. Angiogenesis Original Paper Angiogenic sprouting, the growth of new blood vessels from pre-existing vessels, is orchestrated by cues from within the cellular microenvironment, such as biochemical gradients and perfusion. However, many of these cues are missing in current in vitro models of angiogenic sprouting. We here describe an in vitro platform that integrates both perfusion and the generation of stable biomolecular gradients and demonstrate its potential to study more physiologically relevant angiogenic sprouting and microvascular stabilization. The platform consists of an array of 40 individually addressable microfluidic units that enable the culture of perfused microvessels against a three-dimensional collagen-1 matrix. Upon the introduction of a gradient of pro-angiogenic factors, the endothelial cells differentiated into tip cells that invaded the matrix. Continuous exposure resulted in continuous migration and the formation of lumen by stalk cells. A combination of vascular endothelial growth factor-165 (VEGF-165), phorbol 12-myristate 13-acetate (PMA), and sphingosine-1-phosphate (S1P) was the most optimal cocktail to trigger robust, directional angiogenesis with S1P being crucial for guidance and repetitive sprout formation. Prolonged exposure forces the angiogenic sprouts to anastomose through the collagen to the other channel. This resulted in remodeling of the angiogenic sprouts within the collagen: angiogenic sprouts that anastomosed with the other perfusion channel remained stable, while those who did not retracted and degraded. Furthermore, perfusion with 150 kDa FITC-Dextran revealed that while the angiogenic sprouts were initially leaky, once they fully crossed the collagen lane they became leak tight. This demonstrates that once anastomosis occurred, the sprouts matured and suggests that perfusion can act as an important survival and stabilization factor for the angiogenic microvessels. The robustness of this platform in combination with the possibility to include a more physiological relevant three-dimensional microenvironment makes our platform uniquely suited to study angiogenesis in vitro. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10456-018-9647-0) contains supplementary material, which is available to authorized users. Springer Netherlands 2018-08-31 2019 /pmc/articles/PMC6510881/ /pubmed/30171498 http://dx.doi.org/10.1007/s10456-018-9647-0 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Paper van Duinen, V. Zhu, D. Ramakers, C. van Zonneveld, A. J. Vulto, P. Hankemeier, T. Perfused 3D angiogenic sprouting in a high-throughput in vitro platform |
title | Perfused 3D angiogenic sprouting in a high-throughput in vitro platform |
title_full | Perfused 3D angiogenic sprouting in a high-throughput in vitro platform |
title_fullStr | Perfused 3D angiogenic sprouting in a high-throughput in vitro platform |
title_full_unstemmed | Perfused 3D angiogenic sprouting in a high-throughput in vitro platform |
title_short | Perfused 3D angiogenic sprouting in a high-throughput in vitro platform |
title_sort | perfused 3d angiogenic sprouting in a high-throughput in vitro platform |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510881/ https://www.ncbi.nlm.nih.gov/pubmed/30171498 http://dx.doi.org/10.1007/s10456-018-9647-0 |
work_keys_str_mv | AT vanduinenv perfused3dangiogenicsproutinginahighthroughputinvitroplatform AT zhud perfused3dangiogenicsproutinginahighthroughputinvitroplatform AT ramakersc perfused3dangiogenicsproutinginahighthroughputinvitroplatform AT vanzonneveldaj perfused3dangiogenicsproutinginahighthroughputinvitroplatform AT vultop perfused3dangiogenicsproutinginahighthroughputinvitroplatform AT hankemeiert perfused3dangiogenicsproutinginahighthroughputinvitroplatform |